STERIS plc (STE)
USD 207.01
(-1.19%)
USD 207.01
(-1.19%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 378.23 Million USD | 253.4% |
| 2023 | 107.03 Million USD | -56.12% |
| 2022 | 243.88 Million USD | -38.63% |
| 2021 | 397.4 Million USD | -2.52% |
| 2020 | 407.65 Million USD | 34.08% |
| 2019 | 304.05 Million USD | 4.52% |
| 2018 | 290.91 Million USD | 164.55% |
| 2017 | 109.96 Million USD | -0.72% |
| 2016 | 110.76 Million USD | -17.99% |
| 2015 | 135.06 Million USD | 4.34% |
| 2014 | 129.44 Million USD | -19.09% |
| 2013 | 159.97 Million USD | 17.53% |
| 2012 | 136.11 Million USD | 165.51% |
| 2011 | 51.26 Million USD | -60.09% |
| 2010 | 128.46 Million USD | 16.07% |
| 2009 | 110.68 Million USD | 43.55% |
| 2008 | 77.1 Million USD | -6.15% |
| 2007 | 82.15 Million USD | 16.88% |
| 2006 | 70.28 Million USD | -18.25% |
| 2005 | 85.98 Million USD | -8.77% |
| 2004 | 94.24 Million USD | 18.64% |
| 2003 | 79.43 Million USD | 71.93% |
| 2002 | 46.2 Million USD | 3408.12% |
| 2001 | 1.31 Million USD | -87.44% |
| 2000 | 10.48 Million USD | -87.65% |
| 1999 | 84.9 Million USD | 29.63% |
| 1998 | 65.49 Million USD | 314.04% |
| 1997 | -30.6 Million USD | -339.06% |
| 1996 | 12.8 Million USD | 47.13% |
| 1995 | 8.7 Million USD | 38.1% |
| 1994 | 6.3 Million USD | 152.0% |
| 1993 | 2.5 Million USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 115.31 Million USD | -6.67% |
| 2024 FY | 378.23 Million USD | 253.4% |
| 2024 Q3 | 140.74 Million USD | 22.05% |
| 2024 Q4 | -1.37 Million USD | -100.98% |
| 2024 Q1 | 123.55 Million USD | -34.01% |
| 2023 FY | 107.03 Million USD | -56.12% |
| 2023 Q2 | -315.28 Million USD | -383.37% |
| 2023 Q1 | 111.26 Million USD | 112.9% |
| 2023 Q3 | 123.82 Million USD | 139.27% |
| 2023 Q4 | 187.22 Million USD | 51.2% |
| 2022 Q1 | -21.8 Million USD | -124.94% |
| 2022 FY | 243.88 Million USD | -38.63% |
| 2022 Q2 | 69.81 Million USD | 420.13% |
| 2022 Q3 | 143.62 Million USD | 105.73% |
| 2022 Q4 | 52.26 Million USD | -63.61% |
| 2021 FY | 397.4 Million USD | -2.52% |
| 2021 Q4 | 87.44 Million USD | -23.63% |
| 2021 Q1 | 88.19 Million USD | -28.48% |
| 2021 Q3 | 114.5 Million USD | 8.16% |
| 2021 Q2 | 105.85 Million USD | 20.03% |
| 2020 FY | 407.65 Million USD | 34.08% |
| 2020 Q2 | 94.76 Million USD | 12.03% |
| 2020 Q3 | 104.93 Million USD | 10.72% |
| 2020 Q4 | 123.31 Million USD | 17.52% |
| 2020 Q1 | 84.59 Million USD | -22.21% |
| 2019 Q4 | 108.74 Million USD | 127.22% |
| 2019 Q3 | 47.85 Million USD | -38.21% |
| 2019 Q2 | 77.45 Million USD | 10.67% |
| 2019 FY | 304.05 Million USD | 4.52% |
| 2019 Q1 | 69.99 Million USD | -4.9% |
| 2018 Q4 | 73.59 Million USD | -22.35% |
| 2018 FY | 290.91 Million USD | 164.55% |
| 2018 Q3 | 94.78 Million USD | 47.04% |
| 2018 Q2 | 64.45 Million USD | 10.99% |
| 2018 Q1 | 58.07 Million USD | 122.15% |
| 2017 Q3 | -4.99 Million USD | -112.36% |
| 2017 FY | 109.96 Million USD | -0.72% |
| 2017 Q1 | 48.4 Million USD | -16.17% |
| 2017 Q2 | 40.41 Million USD | -16.5% |
| 2017 Q4 | 26.14 Million USD | 623.28% |
| 2016 Q1 | 24.29 Million USD | -41.32% |
| 2016 Q2 | 8.68 Million USD | -64.24% |
| 2016 Q3 | 20.04 Million USD | 130.75% |
| 2016 Q4 | 57.74 Million USD | 188.05% |
| 2016 FY | 110.76 Million USD | -17.99% |
| 2015 FY | 135.06 Million USD | 4.34% |
| 2015 Q2 | 31 Million USD | 26.36% |
| 2015 Q1 | 24.53 Million USD | -36.88% |
| 2015 Q3 | 38.12 Million USD | 22.96% |
| 2015 Q4 | 41.39 Million USD | 8.59% |
| 2014 Q3 | 28.5 Million USD | -4.16% |
| 2014 Q4 | 38.87 Million USD | 36.38% |
| 2014 FY | 129.44 Million USD | -19.09% |
| 2014 Q1 | 32.31 Million USD | -21.9% |
| 2014 Q2 | 29.74 Million USD | -7.96% |
| 2013 Q3 | 48.09 Million USD | 19.81% |
| 2013 Q4 | 41.38 Million USD | -13.96% |
| 2013 FY | 159.97 Million USD | 17.53% |
| 2013 Q1 | 30.35 Million USD | -31.28% |
| 2013 Q2 | 40.14 Million USD | 32.26% |
| 2012 Q4 | 44.17 Million USD | 31.27% |
| 2012 Q1 | 28.73 Million USD | -26.33% |
| 2012 Q3 | 33.64 Million USD | 13.82% |
| 2012 FY | 136.11 Million USD | 165.51% |
| 2012 Q2 | 29.56 Million USD | 2.9% |
| 2011 Q4 | 39 Million USD | 79.19% |
| 2011 Q1 | -45.21 Million USD | -251.53% |
| 2011 Q2 | 35.71 Million USD | 178.99% |
| 2011 Q3 | 21.76 Million USD | -39.05% |
| 2011 FY | 51.26 Million USD | -60.09% |
| 2010 Q3 | 41 Million USD | 27.81% |
| 2010 FY | 128.46 Million USD | 16.07% |
| 2010 Q2 | 32.08 Million USD | 25.61% |
| 2010 Q4 | 29.83 Million USD | -27.24% |
| 2010 Q1 | 25.54 Million USD | -8.18% |
| 2009 FY | 110.68 Million USD | 43.55% |
| 2009 Q1 | 25.5 Million USD | -2.33% |
| 2009 Q4 | 27.81 Million USD | -2.66% |
| 2009 Q3 | 28.57 Million USD | -0.76% |
| 2009 Q2 | 28.79 Million USD | 12.92% |
| 2008 Q4 | 26.1 Million USD | 19.9% |
| 2008 FY | 77.1 Million USD | -6.15% |
| 2008 Q2 | 16.01 Million USD | 21.32% |
| 2008 Q1 | 13.2 Million USD | -55.71% |
| 2008 Q3 | 21.77 Million USD | 35.95% |
| 2007 Q2 | 16.36 Million USD | 11.41% |
| 2007 Q3 | 21.29 Million USD | 30.19% |
| 2007 Q4 | 29.8 Million USD | 39.95% |
| 2007 FY | 82.15 Million USD | 16.88% |
| 2007 Q1 | 14.68 Million USD | 73.69% |
| 2006 Q4 | 8.45 Million USD | -69.9% |
| 2006 Q2 | 16.41 Million USD | -5.29% |
| 2006 Q1 | 17.33 Million USD | -30.71% |
| 2006 Q3 | 28.08 Million USD | 71.12% |
| 2006 FY | 70.28 Million USD | -18.25% |
| 2005 Q2 | 18.89 Million USD | 7.24% |
| 2005 Q3 | 24.45 Million USD | 29.45% |
| 2005 FY | 85.98 Million USD | -8.77% |
| 2005 Q4 | 25.01 Million USD | 2.27% |
| 2005 Q1 | 17.61 Million USD | -41.88% |
| 2004 Q1 | 16.47 Million USD | -38.33% |
| 2004 Q3 | 27.09 Million USD | 33.01% |
| 2004 Q2 | 20.36 Million USD | 23.66% |
| 2004 Q4 | 30.3 Million USD | 11.87% |
| 2004 FY | 94.24 Million USD | 18.64% |
| 2003 Q2 | 18.41 Million USD | 43.45% |
| 2003 Q3 | 21.48 Million USD | 16.67% |
| 2003 FY | 79.43 Million USD | 71.93% |
| 2003 Q1 | 12.83 Million USD | -30.99% |
| 2003 Q4 | 26.71 Million USD | 24.35% |
| 2002 Q3 | 14 Million USD | 51.89% |
| 2002 Q1 | 4.38 Million USD | 126.36% |
| 2002 FY | 46.2 Million USD | 3408.12% |
| 2002 Q4 | 18.59 Million USD | 32.81% |
| 2002 Q2 | 9.21 Million USD | 110.34% |
| 2001 Q2 | 6.72 Million USD | 712.08% |
| 2001 FY | 1.31 Million USD | -87.44% |
| 2001 Q4 | -16.62 Million USD | -260.0% |
| 2001 Q1 | 828 Thousand USD | 103.42% |
| 2001 Q3 | 10.39 Million USD | 54.54% |
| 2000 Q4 | -24.21 Million USD | -322.16% |
| 2000 FY | 10.48 Million USD | -87.65% |
| 2000 Q3 | 10.9 Million USD | -24.31% |
| 2000 Q2 | 14.4 Million USD | 54.84% |
| 2000 Q1 | 9.3 Million USD | -67.71% |
| 1999 Q4 | 28.8 Million USD | 25.22% |
| 1999 FY | 84.9 Million USD | 29.63% |
| 1999 Q1 | 14.34 Million USD | -29.23% |
| 1999 Q2 | 18.8 Million USD | 31.06% |
| 1999 Q3 | 23 Million USD | 22.34% |
| 1998 Q3 | 18.17 Million USD | 18.69% |
| 1998 FY | 65.49 Million USD | 314.04% |
| 1998 Q1 | 11.74 Million USD | -26.12% |
| 1998 Q2 | 15.3 Million USD | 30.32% |
| 1998 Q4 | 20.27 Million USD | 11.56% |
| 1997 Q3 | 13.5 Million USD | 17.39% |
| 1997 Q1 | -71.6 Million USD | -1935.9% |
| 1997 FY | -30.6 Million USD | -339.06% |
| 1997 Q4 | 15.9 Million USD | 17.78% |
| 1997 Q2 | 11.5 Million USD | 116.06% |
| 1996 Q2 | 2.9 Million USD | 16.0% |
| 1996 FY | 12.8 Million USD | 47.13% |
| 1996 Q4 | 3.9 Million USD | 11.43% |
| 1996 Q3 | 3.5 Million USD | 20.69% |
| 1996 Q1 | 2.5 Million USD | -3.85% |
| 1995 Q2 | 1.9 Million USD | 5.56% |
| 1995 Q3 | 2.4 Million USD | 26.32% |
| 1995 Q4 | 2.6 Million USD | 8.33% |
| 1995 FY | 8.7 Million USD | 38.1% |
| 1995 Q1 | 1.8 Million USD | 12.5% |
| 1994 Q2 | 1.1 Million USD | -50.0% |
| 1994 Q4 | 1.6 Million USD | 14.29% |
| 1994 Q3 | 1.4 Million USD | 27.27% |
| 1994 Q1 | 2.2 Million USD | 100.0% |
| 1994 FY | 6.3 Million USD | 152.0% |
| 1993 Q1 | 200 Thousand USD | 0.0% |
| 1993 FY | 2.5 Million USD | 0.0% |
| 1993 Q2 | 400 Thousand USD | 100.0% |
| 1993 Q3 | 700 Thousand USD | 75.0% |
| 1993 Q4 | 1.1 Million USD | 57.14% |
| 1992 Q2 | -200 Thousand USD | 0.0% |
| 1992 Q4 | - USD | 100.0% |
| 1992 FY | - USD | 0.0% |
| 1992 Q1 | -200 Thousand USD | 0.0% |
| 1992 Q3 | -100 Thousand USD | 50.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q3 | - USD | -100.0% |
| 1991 Q1 | -100 Thousand USD | 0.0% |
| 1991 Q2 | 100 Thousand USD | 200.0% |
| 1991 Q4 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott Laboratories | 5.72 Billion USD | 93.391% |
| Allurion Technologies Inc. | -82.3 Million USD | 559.563% |
| Artivion, Inc. | -30.69 Million USD | 1332.45% |
| Avanos Medical, Inc. | -61.8 Million USD | 712.037% |
| Butterfly Network, Inc. | -133.69 Million USD | 382.901% |
| Butterfly Network, Inc. | -133.69 Million USD | 382.901% |
| Bio-Rad Laboratories, Inc. | -637.32 Million USD | 159.348% |
| Boston Scientific Corporation | 1.59 Billion USD | 76.256% |
| Perspective Therapeutics, Inc. | -14.67 Million USD | 2678.316% |
| CONMED Corporation | 64.45 Million USD | -486.79% |
| Edwards Lifesciences Corporation | 1.4 Billion USD | 73.029% |
| Paragon 28, Inc. | -47.84 Million USD | 890.617% |
| Glaukos Corporation | -134.66 Million USD | 380.882% |
| Globus Medical, Inc. | 122.87 Million USD | -207.829% |
| Inspire Medical Systems, Inc. | -21.15 Million USD | 1888.11% |
| Integer Holdings Corporation | 90.65 Million USD | -317.252% |
| Medtronic plc | 3.67 Billion USD | 89.711% |
| Nevro Corp. | -92.21 Million USD | 510.18% |
| Owlet, Inc. | -32.9 Million USD | 1249.628% |
| Penumbra, Inc. | 90.95 Million USD | -315.857% |
| Vicarious Surgical Inc. | -71.07 Million USD | 632.199% |
| Smith & Nephew plc | 263 Million USD | -43.817% |
| Sonendo, Inc. | -60.91 Million USD | 720.888% |
| Stryker Corporation | 3.16 Billion USD | 88.049% |
| Vapotherm, Inc. | -58.19 Million USD | 749.973% |
| Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | 63.063% |